MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · IEX Real-Time Price · USD
1.010
-0.030 (-2.88%)
At close: May 17, 2024, 4:00 PM
1.060
+0.050 (4.95%)
After-hours: May 17, 2024, 7:21 PM EDT
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $35.60 million as of May 17, 2024. Its market cap has decreased by -36.21% in one year.
Market Cap
35.60M
Enterprise Value
33.99M
1-Year Change
-36.21%
Ranking
Category
Stock Price
$1.01
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $35.60M, a decrease of -90.79%. That is a compound annual growth rate of -60.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 35.10M | -2.77% |
May 16, 2024 | 36.10M | - |
May 15, 2024 | 36.10M | -7.20% |
May 14, 2024 | 38.90M | 14.41% |
May 13, 2024 | 34.00M | 8.97% |
May 10, 2024 | 31.20M | - |
May 9, 2024 | 31.20M | -3.41% |
May 8, 2024 | 32.30M | - |
May 7, 2024 | 32.30M | -1.22% |
May 6, 2024 | 32.70M | -3.82% |
May 3, 2024 | 34.00M | 1.19% |
May 2, 2024 | 33.60M | 1.51% |
May 1, 2024 | 33.10M | -3.78% |
Apr 30, 2024 | 34.40M | 4.24% |
Apr 29, 2024 | 33.00M | 2.48% |
Apr 26, 2024 | 32.20M | 6.62% |
Apr 25, 2024 | 30.20M | -1.95% |
Apr 24, 2024 | 30.80M | 1.99% |
Apr 23, 2024 | 30.20M | -2.58% |
Apr 22, 2024 | 31.00M | 1.97% |
Apr 19, 2024 | 30.40M | 0.33% |
Apr 18, 2024 | 30.30M | -4.42% |
Apr 17, 2024 | 31.70M | 1.28% |
Apr 16, 2024 | 31.30M | -0.63% |
Apr 15, 2024 | 31.50M | -7.89% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Owlet | 36.46M |
Co-Diagnostics | 36.13M |
SAB Biotherapeutics | 35.70M |
Rapid Micro Biosystems | 35.58M |
Brainstorm Cell Therapeutics | 35.48M |
Acurx Pharmaceuticals | 35.33M |
ProMIS Neurosciences | 35.08M |
Akili | 34.35M |